Holen Sie sich die Stockscreener-App
3.66
9.25%
0.31
Handel nachbörslich:
3.71
0.05
+1.37%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt BMRA?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$3.35
Offen:
$3.5
24-Stunden-Volumen:
310.98K
Relative Volume:
2.43
Marktkapitalisierung:
$1.07M
Einnahmen:
$5.51M
Nettoeinkommen (Verlust:
$-6.16M
KGV:
-9.8919
EPS:
-0.37
Netto-Cashflow:
$-5.03M
1W Leistung:
+8.90%
1M Leistung:
-33.23%
6M Leistung:
+49.02%
1J Leistung:
-36.63%
1-Tages-Spanne:
$3.44
$3.93
1-Wochen-Bereich:
$3.1754
$4.07
52-Wochen-Spanne:
$1.932
$10.16
Biomerica Inc Stock (BMRA) Company Profile
Firmenname
Biomerica Inc
Sektor
Branche
Telefon
(949) 379-2875
Adresse
17571 VON KARMAN AVENUE, IRVINE, CA
Vergleichen Sie BMRA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BMRA
Biomerica Inc
|
3.66 | 1.07M | 5.51M | -6.16M | -5.03M | -0.37 |
|
ABT
Abbott Laboratories
|
129.84 | 224.94B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
98.92 | 140.88B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
357.11 | 132.32B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
83.75 | 107.39B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
70.46 | 41.71B | 5.72B | 4.17B | 259.90M | 6.97 |
Biomerica Inc Stock (BMRA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2020-11-10 | Eingeleitet | Colliers Securities | Buy |
| 2018-01-04 | Eingeleitet | B. Riley FBR, Inc. | Buy |
Biomerica Inc Aktie (BMRA) Neueste Nachrichten
Biomerica announces Fortel Ulcer Test approved for sale by UAE Ministry - TipRanks
Biomerica (BMRA) Gains UAE Approval for Fortel Ulcer Test | BMRA Stock News - GuruFocus
United Arab Emirates Ministry of Health and Prevention Approves Biomerica's Fortel® Ulcer Test for Detection of H. pylori Infection - The Manila Times
United Arab Emirates Ministry of Health and Prevention Approves Biomerica's Fortel® Ulcer Test for Detection of H. pylori Infection | BMRA Stock News - GuruFocus
BMRA Stock Might Surge: Biomerica’s New Ulcer Test Now Available Across the UAE - Own Snap
United Arab Emirates Ministry Of Health And Prevention Approves Biomerica'S Fortel® Ulcer Test For Detection Of H. Pylori Infection - marketscreener.com
Biomerica Secures Major UAE Approval for Rapid H. Pylori Test as Middle East Expansion Accelerates - Stock Titan
BMRA stock touches 52-week high of $3.84 amid market fluctuations - Investing.com
Financial Health Report: Biomerica Inc (BMRA)’s Ratios Tell a Tale - DWinneX
BMRA stock touches 52-week high of $3.84 amid market fluctuations By Investing.com - Investing.com South Africa
Biomerica’s kidney disease test gains approval for sale in UAE - Yahoo Finance
Biomerica stock plummets on 1-for-8 reverse stock split - MSN
Biomerica’s kidney disease test approved for UAE market By Investing.com - Investing.com Canada
Walmart to Expand Sales of BiomericaÆS Aware Breast Self Exam; Product Will Now Be Available in over 2400 Walmart Stores - marketscreener.com
Biomerica (BMRA) Gains UAE Approval for Fortel Kidney Disease Te - GuruFocus
BiomericaFortel Kidney Disease Test Approved For Sale In UAE - marketscreener.com
Biomerica’s kidney disease test approved for UAE market - Investing.com Australia
United Arab Emirates Ministry of Health and Prevention Approves Biomerica's Fortel® Kidney Disease Test for Early Detection of Kidney Damage | BMRA Stock News - GuruFocus
United Arab Emirates Ministry of Health and Prevention Approves Biomerica's Fortel® Kidney Disease Test for Early Detection of Kidney Damage - The Manila Times
Revolutionary 10-Minute Test Could Help Detect Hidden Kidney Disease in 80% of At-Risk Patients - Stock Titan
Biomerica Stock Set to Reverse Split on Monday, April 21st (NASDAQ:BMRA) - Defense World
Biomerica announces reverse stock split - Medical Buyer
Biomerica announces reverse stock split to meet Nasdaq requirements - Investing.com Australia
Biomerica announces reverse stock split to meet Nasdaq requirements By Investing.com - Investing.com Canada
Biomerica Stock Slumps After Reverse Stock Split Announcement: Retail’s Disappointed - MSN
Crude Oil Moves Higher; Travelers Earnings Beat Estimates - Benzinga
Biomerica Announced 1-for-8 Reverse Stock Split - Nasdaq
Biomerica Plans Reverse Stock Split to Regain Nasdaq Listing Compliance - MarketScreener
Biomerica Announces 1-for-8 Reverse Stock Split To Regain Nasdaq Compliance - Nasdaq
Nasdaq Down Over 2%; Abbott Laboratories Posts Upbeat Earnings - Benzinga
Biomerica (BMRA) Announces 1-for-8 Reverse Stock Split Effective April 2025 | BMRA Stock News - GuruFocus
Biomerica Announces Reverse Stock Split | BMRA Stock News - GuruFocus
Biomerica Announces Reverse Stock Split Effective April 21 - TipRanks
Biomerica, Inc. Announces 1-for-8 Reverse Stock Split Effective April 21, 2025 - Nasdaq
Biomerica's Strategic 1:8 Reverse Split Aims to Secure Nasdaq Future - Stock Titan
3 High-Value Companies With Triple-Digit Upside Potential - The Globe and Mail
Biomerica Reports Third Quarter Fiscal 2025 Financial Results - ADVFN
Biomerica Reports Third Quarter Fiscal 2025 Financial Results | - GuruFocus
Biomerica (BMRA) Reports Q3 Revenue Increase and Lower Expenses - GuruFocus
Wheat Losses Continuing on Tuesday Morning - The Globe and Mail
Biomerica Turns Corner: 10% Growth, Cost Cuts, and Major Regulatory Wins Boost Q3 Results - Stock Titan
BIOMERICA INC SEC 10-Q Report - TradingView
La Mancha Investment buying more Belo Sun Mining (BSX) - The Globe and Mail
Biomerica (NASDAQ:BMRA) Share Price Passes Above Two Hundred Day Moving Average – Here’s Why - Defense World
Biomerica (NASDAQ:BMRA) Stock Price Crosses Above 200-Day Moving Average – Should You Sell? - Defense World
Enteric Disease Testing Market Set to Witness Significant - openPR.com
Biomerica, Inc. (NASDAQ:BMRA) Short Interest Down 65.5% in March - Defense World
Biomerica (NASDAQ:BMRA) Share Price Crosses Above 200 Day Moving Average – Here’s What Happened - Defense World
Short Interest in Biomerica, Inc. (NASDAQ:BMRA) Grows By 64.6% - Defense World
Biomerica’s tests for IBD conditions gain CE-marking under EU’s IVDR - Yahoo
Biomerica gains EU certification for IBD food intolerance products By Investing.com - Investing.com South Africa
Finanzdaten der Biomerica Inc-Aktie (BMRA)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.06%
0.20%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):